Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement
- 11 March 2010
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 67 (1) , 127-136
Abstract
Background Although gastric cancer with isolated para-aortic lymph node (PAN) involvement is considered an advanced disease, the clinical characteristics of it have not been comprehensively elucidated. Patients and methods We reviewed the medical records of 1,277 patients received palliative chemotherapy with advanced gastric cancer according to metastatic sites: PAN-only metastasis, single organ metastasis other than PAN, and multiple organ metastasis. Time to other organ metastasis (TTOM) was determined only in PAN-only metastasis group as the time interval between initial diagnosis of recurrence or de novo metastasis and confirming distant metastasis beyond PAN area. Results The median overall survival (OS) of patients with PAN-only metastasis was significantly longer than that of patients with single organ metastasis other than PAN or multiple organ metastasis (13.8 months vs. 11.4 months vs. 8.4 months; P < 0.001). In the PAN-only metastasis group, patients with recurrent diseases showed longer TTOM beyond the PAN area (10.7 vs. 7.7 months; P = 0.037) and OS (23.8 vs. 12.8 months; P = 0.010) than those with de novo metastatic disease and it was validated by multivariate analysis. Conclusion Patients with isolated PAN metastasis showed an excellent prognosis compared with patients with metastasis at other sites and it was primarily evident in patients with recurrent PAN metastasis.Keywords
This publication has 20 references indexed in Scilit:
- Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancerInternational Journal of Clinical Oncology, 2008
- Effect of timing of metastasis/disease recurrence and histologic differentiation on survival of patients with advanced gastric cancerCancer, 2007
- Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinomaAnnals of Oncology, 2007
- Candidates for Curative Resection in Advanced Gastric Cancer Patients Who Had Equivocal Para-aortic Lymph Node Metastasis on Computed Tomographic ScanAnnals of Surgical Oncology, 2006
- Results and Controversial Issues Regarding a Para-Aortic Lymph Node Dissection for Advanced Gastric CancerSurgery Today, 2005
- Patterns of Initial Recurrence in Completely Resected Gastric AdenocarcinomaAnnals of Surgery, 2004
- Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient DataJournal of Clinical Oncology, 2004
- Classification of Regional Lymph Nodes in JapanInternational Journal of Clinical Oncology, 2003
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- Recurrence following curative resection for gastric carcinomaBritish Journal of Surgery, 2000